Evidence map›Paper›PMID 34197951›Full record

ArticleClinical immunology (Orlando, Fla.)2022

Severe COVID-19 pneumonia in Good syndrome with a favorable outcome.

Maria Lourdes Cos Esquius, Inmaculada López Montesinos, Ramón Gimeno Martinez, Jorge Eguía Núñez, M Araceli Caballero-Rabasco, Blanca Sánchez González, Alicia López García, Leonardo Mellibovsky

Open access · greenAbstract readLetterComment
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. COVID-19 and Inborn Errors of Immunity.Physiology (Bethesda, Md.) · 2022
    Review
  7. Article
  8. A Case of Severe COVID-19 in a Patient with Good's Syndrome.European journal of case reports in internal medicine · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria Lourdes Cos EsquiusInternal Medicine Service, Hospital del Mar, Barcelona, Spain; Functional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain.
Inmaculada López MontesinosInfectious Diseases Service, Hospital del Mar, Barcelona, Spain.
Ramón Gimeno MartinezImmunology Laboratory, Department of Pathology, Hospital del Mar, Barcelona, Spain; Functional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain.
Jorge Eguía NúñezImmunology Area, Laboratori de Referència de Catalunya S.A., Spain; Functional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain.
M Araceli Caballero-RabascoPediatric Pulmonology Unit, Department of Pediatrics, Hospital del Mar, Spain; Functional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain.
Blanca Sánchez GonzálezHematology Department, Hospital del Mar, Spain; Functional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain.
Alicia López GarcíaDepartment of Gastroenterology, Hospital del Mar, Barcelona, Spain; Functional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain.
Leonardo MellibovskyFunctional Unit of Primary Immunodeficiencies, Hospital del Mar, Barcelona, Spain. Electronic address: 18174@psmar.cat.
Hospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Primary Immunodeficiency DiseasesThymomaThymus NeoplasmsHumansSARS-CoV-2Cellular immunityCOVID-19Good's syndrome (GS)SARS-CoV-2

Identifiers

PMID34197951
PMCPMC8239200
OpenAlexW3173878204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.